Financial Performance - Q3 2024 bookings increased by 51% quarter-over-quarter to 8.9million,anda227.3 million in Q3 2023[2]. - Total revenue for Q3 2024 was 7.5million,aslightdecreaseof17.6 million in Q3 2023[7]. - Net income for Q3 2024 was 0.6million,or0.05 per diluted share, compared to 1.6million,or0.15 per diluted share, in Q3 2023[10]. - Adjusted EBITDA for Q3 2024 was 1.1million,down622.9 million in Q3 2023[10][16]. - Total revenue for the three months ended September 30, 2024, was 7,484,269,adecreaseof1.027,561,582 in the same period of 2023[19]. - Net income for the three months ended September 30, 2024, was 583,101,down64.31,634,790 in the same period of 2023[19]. - Net income for the nine months ended September 30, 2024, was 3,000,002,adecreasefrom5,607,804 in the same period of 2023, representing a decline of approximately 46.4%[20]. Cost and Expenses - Gross margin improved to 73%, up from 71% in the prior year period, reflecting a lower cost of sales[2][8]. - Net operating expenses increased by 28% to 4.7million,drivenbyinvestmentsinstaffandexpandedsalesandmarketingefforts[9].−Operatingexpensesincreasedto4,742,341 for the three months ended September 30, 2024, compared to 3,716,463intheprioryear,representingariseof27.5724,757, up from 487,388inthesameperiodof2023,indicatingagrowthof48.619,668,455, an increase from 18,849,842asofDecember31,2023[18].−Totalcurrentassetsdecreasedto44,942,232 as of September 30, 2024, from 48,995,288asofDecember31,2023,adeclineof8.38,661,418 compared to a negative 11,131,628inthepreviousyear,indicatingimprovedcollectionefforts[20].−Cashandrestrictedcashattheendoftheperiodtotaled19,668,455, up from 17,201,178,markinganincreaseofapproximately14.32,669,269 from 4,365,751,reflectingadeclineofabout38.71,692,249 from 512,249,indicatingincreasedinvestmentinpropertyandequipment[20].−Netcashusedinfinancingactivitieswas158,408, slightly higher than 135,921inthepreviousyear,reflectingongoingfinancingefforts[20].−Thecompanyexperiencedanetincreaseincashof818,612, a significant drop from 3,717,581inthesameperiodlastyear,indicatingtightercashflowmanagement[20].LiabilitiesandEquity−Totalliabilitiesdecreasedsignificantlyto19,918,340 as of September 30, 2024, from 27,012,175asofDecember31,2023,areductionof26.146,150,037 as of September 30, 2024, from 42,621,867asofDecember31,2023,reflectingagrowthof8.513,662,995 as of September 30, 2024, compared to 10,662,993asofDecember31,2023[18].StrategicInitiatives−ThelaunchofthenewV−XRextendedrealitysolutionisexpectedtobroadenofferingsandopenavenuesintoadjacentmarketssuchashealthcareandeducation[3].−ThecompanyisoptimisticaboutcapitalizingonemergingopportunitiesasitmovesthroughQ4andinto2025,despitemacroeconomicuncertainties[6].−Astrongbacklogoflong−termcontractsreflectscontinueddemandandprovidesasteadyrevenuefoundation[11].OtherFinancialMetrics−Interestpaidduringtheperiodwas182,419, with taxes paid amounting to 5,315,442,indicatingongoingfinancialobligations[20].−Thecompanyissued20,151RSUsduringtheperiod,downfrom41,903inthepreviousyear,reflectingadecreaseinequitycompensation[20].−Inventorynetincreasedby1,507,068, compared to an increase of $1,183,302 in the prior year, suggesting a potential buildup of stock[20].